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The Paper of the Year Award was established in 2008 by Environmental 
Health Perspectives (EHP) as a means of reinforcing high-quality articles 
published in the journal, identifying emerging research themes, and 
tracking the impact of groundbreaking research (Tilson 2008). In 
this issue, we are pleased to announce that the EHP Paper of the Year 
for 2009 is “Decrease in Anogenital Distance among Male Infants 
with Prenatal Phthalate Exposure” by Shanna H. Swan, Katharina M. 
Main, Fan Liu, Sara L. Stewart, Robin L. Kruse, Antonia M. Calafat, 
Catherine S. Mao, J. Bruce Redmon, Christine L. Ternand, Shannon 
Sullivan, J. Lynn Teague, and the Study for Future Families Research 
Team (Swan et al. 2005). We chose this paper because of its high 
impact in both the research and legislative realms since its publication 
in 2005.
This paper (Swan et al. 2005) was the first to demonstrate an asso-
ciation between pregnant women’s exposure to phthalates and adverse 
effects on genital development in their male children. Rodent studies 
had previously identified a syndrome of adverse effects of phthalates on 
the male reproductive system (Foster 2006; Sharpe 2005), and find-
ings from Swan et al. (2005) supported the hypothesis that prenatal 
phthalate exposure at environmental levels can also adversely affect male 
reproductive development in humans. These findings are important 
because humans are commonly exposed to phthalates found in a wide 
variety of consumer products, including soft vinyl items, medical tubing 
and IV bags, and a variety of personal care products such as perfume, 
lotion, shampoo, cosmetics, nail polish, and hairspray. 
Toxicologists routinely measure the external genitalia to assess repro-
ductive toxicity in animal studies. One of these measures, anogenital dis-
tance (AGD)—a particularly sensitive indicator of masculinization—is 
shortened in male rodents following prenatal exposure to several phtha-
lates (Foster 2006; Sharpe 2005). Swan et al. (2005) translated the 
standard animal exam to humans in order to investigate potential effects 
of phthalates on reproductive development in male infants. Specifically, 
they estimated associations between the presence and quantity of nine 
phthalate metabolites in mothers’ prenatal urine samples and AGD 
and other measurements in their sons. Higher levels of four phthalate 
metabolites [mono  ethyl phthalate (MEP), mono-n-butyl phthalate 
(MBP), mono  benzyl phthalate (MBzP), and mono  isobutyl phthalate 
(MiBP)] were associated with a shorter AGD. Swan subsequently repli-
cated and extended these findings (2008). 
Swan et al. (2005) has had an impact on phthalate legislation such 
as the Consumer Product Safety Improvement Act of 2008, which 
dramatically reduced the amount of six phthalates (including DEHP 
and DBP) that are permissible in children’s toys. The findings of 
Swan et al. (2005) have also been discussed 
and documented in numerous congressional 
hearings, including the June 2008 House 
Subcommittee on Commerce, Trade, and 
Consumer Protection hearing (Committee 
on Energy and Commerce 2008). This 
research was also cited heavily in support of 
regulations passed in California, Vermont, 
and Washington and introduced in Maine, 
New York, New Jersey, Connecticut, Maryland, Massachusetts, Rhode 
Island, West Virginia, Minnesota, Illinois, Oregon, and Hawaii. 
The AGD measure developed by Swan et al. (2005) is now being 
incorporated into multiple ongoing studies. The National Children’s Study 
(NCS), for example, proposes to include AGD using a similar protocol in 
the infant exam being piloted in the NCS Vanguard Centers (National 
Children’s Study 2009). In addition, Swan and colleagues expect fund-
ing in mid-2009 for a new multi  center pregnancy cohort study that will 
examine prenatal phthalate exposure in relation to AGD and other repro-
ductive parameters in a larger population using more precise methods. This 
research will provide standards for measuring genital landmarks obtained in 
a diverse population-based sample of male infants, which may be suitable 
for use in pediatric practice. Associations between phthalate metabolites 
and these androgen-sensitive measures could further impact public health 
policy, given the ubiquitous nature of these exposures and the clinical 
importance of appropriate androgen stimulation during fetal development.
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Integrity in science has been a long-time priority for Environmental Health Perspectives. Our concern about this issue is reflected in our 
Instructions to Authors, which outlines our expectations concerning full disclosure of competing financial and nonfinancial interests and 
potential penalties that could be imposed if journal policy is not followed.
In this issue is an editorial by Jennifer Sass concerning key elements of effective and practical disclosure policies for health science 
journals. EHP staff participated in the development of the document mentioned in the editorial, and we fully endorse recommendations 
concerning the need for full disclosure of competing interests. As further indication of our commitment to maintaining a high degree 
of scientific integrity, EHP has made the decision to designate a staff member to serve as Ethics Coordinator. The Ethics Coordinator is 
responsible for ensuring appropriate compliance related to conflict of interest declarations required for each paper, assessing alleged conflicts 
of interest and plagiarism, and assisting the Editor-in-Chief in assessing potential conflicts of interest of reviewers. Science has made and 
will continue to make important contributions to the progress of human society. We should, however, be aware that continued support for 
research is dependent on the perceived integrity of the scientific process. EHP remains dedicated to serving as an independent and unbiased 
venue for the discussion of the impact of the environment on human health. 
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